PT  - JOURNAL ARTICLE
AU  - Hasan M. Daghriri
AU  - Alwaleed A. Alrajhi
AU  - Khadijah S. Aburasain
AU  - Ebtisam A. Ateya
AU  - Mohammed A. Hakami
AU  - Ibrahim M. Gosadi
TI  - An assessment of cerebral venous thrombosis risk factors and associated clinical outcomes in Jazan region, Saudi Arabia
AID  - 10.17712/nsj.2021.1.20200098
DP  - 2021 Jan 01
TA  - Neurosciences Journal
PG  - 15--20
VI  - 26
IP  - 1
4099  - http://nsj.org.sa/content/26/1/15.short
4100  - http://nsj.org.sa/content/26/1/15.full
SO  - Neurosciences (Riyadh)2021 Jan 01; 26
AB  - Objectives: To assess cerebral venous thrombosis risk factors, and associated clinical outcomes in Jazan region, Kingdom of Saudi Arabia.Methods: This study is a retrospective review of the medical records of patients diagnosed with cerebral venous thrombosis and admitted to King Fahad Central Hospital in Jazan between 2010 and 2019. Data concerning socio-demographics, clinical features, risk factors, laboratory, and imaging investigations were retrieved. Furthermore, data about cases management, and outcomes, including death, were collected and analysed.Results: A total of 51 medical records were identified. The majority of the patients were females (68.6%), and the mean age of the patients was 33.3 years, of which three patients were under 18 years old. The most frequently recorded symptom was headache (76.5%), followed by seizure (45.1%). The most commonly recorded risk factor was protein S deficiency (57%), followed by anaemia (51%). Venous infarction and haemorrhage were the most common acute complications (13.7%). The majority of the patients had a favourable prognosis where only 27.5% recovered with disability and only one patient died due to the disease.Conclusion: Clinical presentation of cerebral venous thrombosis in Jazan region is similar to other local and international studies. However, anaemia was recorded as a main risk factor for the disease, which might require further investigation to assess the possible association between prevalence of anaemia in Jazan region and the incidence of cerebral venous thrombosis.